Biomarker coverage: Comprehensive biomarker testing is used by physicians to determine the most effective form of treatment for lung cancer, though insurance coverage for the testing varies by state.

Lung cancer is the second most common cancer in the United States, according to the American Cancer Society and the leading ...

Lung cancer is the leading cause of cancer-related deaths in the United States among both men and women. While people 65 and older are more at risk, those between the ages of 50-77 should consider ...

An annual report by the American Lung Association showed that the five-year survival rate for Black residents was 22.6% vs. 32.5% for white residents.